372 related articles for article (PubMed ID: 11309345)
1. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
Leclerc GJ; Barredo JC
Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of folylpolyglutamate synthetase gene expression in tumor tissues by the polymerase chain reaction: marked variation of expression among leukemia patients.
Lenz HJ; Danenberg K; Schnieders B; Goeker E; Peters GJ; Garrow T; Shane B; Bertino JR; Danenberg PV
Oncol Res; 1994; 6(7):329-35. PubMed ID: 7865908
[TBL] [Abstract][Full Text] [Related]
3. Expression of two alternatively spliced forms of the 5' untranslated region of the GM-CSF receptor alpha chain mRNA.
Chopra R; Kendall G; Gale RE; Thomas NS; Linch DC
Exp Hematol; 1996 May; 24(6):755-62. PubMed ID: 8635532
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
5. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
6. Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts.
Seim I; Collet C; Herington AC; Chopin LK
BMC Genomics; 2007 Aug; 8():298. PubMed ID: 17727735
[TBL] [Abstract][Full Text] [Related]
7. Determinants of antifolate cytotoxicity: folylpolyglutamate synthetase activity during cellular proliferation and development.
Barredo J; Moran RG
Mol Pharmacol; 1992 Oct; 42(4):687-94. PubMed ID: 1435744
[TBL] [Abstract][Full Text] [Related]
8. Tissue specific expression of alternative splice forms of human cyclic nucleotide gated channel subunit CNGA3.
Cassar SC; Chen J; Zhang D; Gopalakrishnan M
Mol Vis; 2004 Oct; 10():808-13. PubMed ID: 15534583
[TBL] [Abstract][Full Text] [Related]
9. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
[TBL] [Abstract][Full Text] [Related]
10. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
[TBL] [Abstract][Full Text] [Related]
12. Structural organization of the human folypoly-gamma-glutamate synthetase gene: evidence for a single genomic locus.
Taylor SM; Freemantle SJ; Moran RG
Cancer Res; 1995 Dec; 55(24):6030-4. PubMed ID: 8521387
[TBL] [Abstract][Full Text] [Related]
13. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines.
Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG
Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465
[TBL] [Abstract][Full Text] [Related]
14. Variants of the 5'-untranslated region of human NCF2: expression and translational efficiency.
Gauss KA; Bunger PL; Crawford MA; McDermott BE; Swearingen R; Nelson-Overton LK; Siemsen DW; Kobayashi SD; Deleo FR; Quinn MT
Gene; 2006 Jan; 366(1):169-79. PubMed ID: 16310324
[TBL] [Abstract][Full Text] [Related]
15. Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.
Jalink M; Ge Z; Liu C; Björkholm M; Gruber A; Xu D
Biochem Biophys Res Commun; 2007 Feb; 353(4):999-1003. PubMed ID: 17204238
[TBL] [Abstract][Full Text] [Related]
16. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
McGuire JJ; Russell CA
Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
[TBL] [Abstract][Full Text] [Related]
17. Expression of P2X7 in human hematopoietic cell lines and leukemia patients.
Zhang XJ; Zheng GG; Ma XT; Yang YH; Li G; Rao Q; Nie K; Wu KF
Leuk Res; 2004 Dec; 28(12):1313-22. PubMed ID: 15475073
[TBL] [Abstract][Full Text] [Related]
18. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
[TBL] [Abstract][Full Text] [Related]
19. Novel splice variants of human ADAR2 mRNA: skipping of the exon encoding the dsRNA-binding domains, and multiple C-terminal splice sites.
Kawahara Y; Ito K; Ito M; Tsuji S; Kwak S
Gene; 2005 Dec; 363():193-201. PubMed ID: 16297572
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of new splice variants of the neurotensin receptor 1 gene in human prostate cancer cell lines.
Almeida TA; Rodriguez Y; Hernández M; Reyes R; Bello AR
Peptides; 2010 Feb; 31(2):242-7. PubMed ID: 20018219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
